Ono Venture Investment, Inc.
South San Francisco, Californiaonoventure.com
Overview
Ono Venture Investment is the corporate venture capital arm of Ono Pharmaceutical, which makes strategic investments in startup companies with cutting-edge technologies, focusing on oncology, immunology, and neurology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Violet Therapeutics | May 2026 | Seed | Co-investor |
| Mediar Therapeutics | Jan 2026 | Series B | Co-investor |
| ResNovas Therapeutics | Dec 2025 | Pre Seed | Co-investor |
| Alchemab Therapeutics | Sep 2025 | Series A Extension | Co-investor |
| Rho Bio | Apr 2025 | Pre Seed | Co-investor |
Key People
Ryohei Miyata
Director, Scientific Relations
Daisuke Nakayama
Senior Investment Director
Haruhito Tsutsui
Investment Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
